Barclays
DBD icon

Barclays’s Diebold Nixdorf DBD Stock Holding History

Barclays’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$550K Sell
7,294
-31,278
-81% -$2.3M ﹤0.01% 3141
2025
Q4 		$2.62M Buy
38,572
+2,307
+6% +$144K ﹤0.01% 2732
2025
Q3 		$2.07M Sell
36,265
-11,369
-24% -$674K ﹤0.01% 2866
2025
Q2 		$2.64M Buy
47,634
+19,013
+66% +$892K ﹤0.01% 2632
2025
Q1 		$1.25M Sell
28,621
-12,175
-30% -$531K ﹤0.01% 2968
2024
Q4 		$1.76M Sell
40,796
-93,787
-70% -$4.22M ﹤0.01% 2982
2024
Q3 		$6.01M Sell
134,583
-82,101
-38% -$3.4M ﹤0.01% 1931
2024
Q2 		$8.34M Buy
216,684
+136,437
+170% +$5.2M ﹤0.01% 1269
2024
Q1 		$2.76M Buy
80,247
+28,736
+56% +$923K ﹤0.01% 2301
2023
Q4 		$1.49M Buy
+51,511
New +$1.17M ﹤0.01% 3149

Other funds holding DBD

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays's DBD Position: Q1 2026 in Review

Barclays reduced its Diebold Nixdorf (DBD) stake by 81% in Q1 2026, selling an estimated $2.3M and leaving 7,294 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #3141.

Barclays first reported a position in DBD in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.34M in Q2 2024. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Barclays held 7,294 shares of Diebold Nixdorf worth $550K as of Q1 2026.
  • Barclays sold 31,278 Diebold Nixdorf shares in Q1 2026, an estimated $2.3M.
  • Diebold Nixdorf made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3141 holding.
  • Barclays first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 10 quarters since.
  • Barclays's Diebold Nixdorf position peaked at $8.34M in Q2 2024.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.